A cutting-edge RNA research facility promised to New South Wales more than four years ago will open its doors by next summer, delivering first-of-its-kind vaccine research and manufacturing capability...
A $96 million RNA pilot manufacturing facility aimed at bridging the gap between research and commercialisation in New South Wales will be established at Macquarie University after the state...
Just eight McKinsey staff are being used on the company’s $2.5 million, three-month contract to provide advice to the federal government on local mRNA vaccine manufacturing, with the global...